All News

The study team previously published research that linked diabetes to elevated rates of certain cancers.

What we're reading, April 27, 2016: Hawaii passes bill to protect transgender patients; childhood obesity has plateaued, not declined; and HHS awards $5 million to Puerto Rico to fight the Zika virus.

An exhaustive analysis of over a 100,000 individuals has confirmed the absence of unbiased association between statin use and a person’s risk of colorectal cancer; however, an inverse relation of risk and cholesterol levels was identified.

Two posters presented at the AMCP Managed Care & Specialty Pharmacy Annual Meeting evaluated opioid misuse and healthcare utilization and cost, as well as a program to flag potential misuse early.

The FDA issued a warning on the SGLT2 inhibitor class in May 2015, but the review by AACE and ACE found that several of the cases involved patients with type 1 disease.

The rule creates the first public reporting system of quality for Medicaid managed care plans.

A randomized, double-blind, placebo-controlled study conducted across 16 countries over a 3-year period has confirmed that Chantix and Zyban do not increase the risk of suicidal behavior among users.

What we're reading, April 26, 2016: the Supreme Court could rule for new process of reviewing drug patents; new Medicaid rules announced; 7 New York insurers will expand coverage of hepatitis C drugs.

Many Americans do not believe there is an association between price and quality in healthcare, according to a study published in Health Affairs.

For optimum utilization of consumer healthcare markets, physicians need to be prepared to help patients navigate out-of-pocket expenses during clinical encounters, researchers found.

Policy solutions were grouped around the themes of transparency, competition, and value. Healthcare heavyweights like Kaiser Permanente, AARP, and the American Hospital Association have signed on to the cause.

Patients diagnosed with advanced renal cell carcinoma, who have received prior treatment with anti-angiogenic agents, now have the option of being treated with the small molecule inhibitor cabozantinib.

It is not surprising that a new study on the relationship between income and longevity in the United States concludes that life expectancy increased with income. However, the study did shed light on the variabilities in the income-longevity relationship.

What we're reading, April 25, 2016: Marilyn Tavenner predicts steep Obamacare insurance premium hikes in 2017; the World Health Organization formally begins looking for its new leader; and the life expectancy between rich and poor young Americans narrows.

A diabetes drug may have benefits for people with chronic heart failure. Boehringer Ingelheim and Eli Lilly and Company have announced plans to investigate the use of the diabetes medicine Jardiance for heart failure with 2 outcome trials.

While healthcare for retirees once meant repeated trips to the doctor’s office, many are now able to receive high-quality medical services without leaving the comfort of home. And it’s all because of telemedicine.

The most important benefit of exercise was the improved ability of the men to fall asleep, the study found.

This week, the top stories in managed care included the news that UnitedHealth will be exiting most Obamacare exchanges in 2017, and coverage from both the annual meeting of the Academy of Managed Care Pharmacy and the Community Oncology Conference.

Fewer than 3% of Americans are active enough, eat a healthy diet, are nonsmokers, and have a healthy weight and percentage of body fat-the 4 important elements of a heart-healthy lifestyle that are promoted by the American Heart Association.

The state's first-in-the-nation waiver to Medicaid seemed endangered in late 2014, but Governor Asa Hutchinson decided keeping people insured was worth it.

The study showed the need to test children with type 1 disease for a lack of vitamin D.

Cost, biosimilars, and technology dominated the conversations when managed care pharmacists, health plan administrators, physicians, and more gathered for the AMCP Managed Care & Specialty Pharmacy Annual Meeting in San Francisco, April 19-22, 2016.

Stories on unsettling data on a rising suicide rate, Louisiana's Medicaid expansion efforts, and a Florida consumer education tool.

To have true utility, value models to assess the worthiness of treatments must have robust processes in place to incorporate the patient voice.

Flatiron Health has announced the development of a cloud-based electronic health record and an analytics tool to support reporting requirements for those clinics that will be selected to participate in the Oncology Care Model.

According to Avalere Health, physicians who prescribe lower cost drugs would be reimbursed at a higher rate than those who use more expensive drugs, under the proposed Medicare Part B demo model.

Since the study period ended, new results show a long-term cardioprotective benefit for empagliflozin and liraglutide.

The American Hospital Association is among those asking for a rating system that reflects socioeconomic differences in hospital populations.